JPH0551315A - Soft capsule type bathing agent and device for producing soft capsule - Google Patents
Soft capsule type bathing agent and device for producing soft capsuleInfo
- Publication number
- JPH0551315A JPH0551315A JP23696591A JP23696591A JPH0551315A JP H0551315 A JPH0551315 A JP H0551315A JP 23696591 A JP23696591 A JP 23696591A JP 23696591 A JP23696591 A JP 23696591A JP H0551315 A JPH0551315 A JP H0551315A
- Authority
- JP
- Japan
- Prior art keywords
- soft capsule
- film
- bathing agent
- capsule type
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Cosmetics (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、溶解性の良い軟カプセ
ル型入浴剤及び軟カプセル製造装置に関するものであ
り、更に詳しくは溶解性を高める為に、軟カプセル型入
浴剤の皮膜を薄くしても皮膜の接着部分は厚く均一な為
に製品の強度を損なったり経時的に内容入浴剤が漏れた
りすることがない安定な軟カプセル型入浴剤及び軟カプ
セル製造装置に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a soft capsule type bathing agent having a good solubility and a soft capsule manufacturing apparatus. More specifically, in order to improve the solubility, the film of the soft capsule type bathing agent is thinned. Even though the adhesive portion of the film is thick and uniform, the present invention relates to a stable soft capsule type bathing agent and a soft capsule manufacturing apparatus which do not impair the strength of the product or leak the content bathing agent over time.
【0002】[0002]
【従来の技術】一般に、浴槽に1粒〜2粒投入すると浴
湯によりゼラチン等の水溶性高分子を基剤とする皮膜が
溶解し、内容入浴剤を放出し、美肌及び保湿効果をもた
らす処の軟カプセル型入浴剤は、1回の使用量が定量化
し易い点や包装を破らずにそのままの形で浴槽に投入で
きる点、又、ホホバ油、オリ−ブ油、ビタミンE等の美
肌及び保湿効果をもたらす油脂や様々の香料成分を粉末
化せずにそのままの形で配合出来る点で優れており、特
に肌への皮脂補給を期待する高齢者や、芳香効果ボディ
−トリ−トメント効果を期待する女性には根強い人気を
博している。2. Description of the Related Art Generally, when one or two tablets are added to a bath, the bath water dissolves a film based on a water-soluble polymer such as gelatin, releases the content of the bath agent, and provides a skin-beautifying and moisturizing effect. The soft capsule type bath agent is easy to quantify the amount used once, and can be put in the bath as it is without breaking the packaging. Also, it can be used for the beautiful skin of jojoba oil, olive oil, vitamin E, etc. It is excellent in that it can mix oils and fats that bring moisturizing effect and various fragrance ingredients as they are without powdering, especially for elderly people who expect to supply sebum to the skin, and aroma effect body treatment effect. It is very popular with the women who expect it.
【0003】ところが、現行の軟カプセル型入浴剤は皮
膜の溶解性が十分でない為に浴湯に投入後、内容入浴剤
を放出してから皮膜が完全に溶解するまでに8〜10分
程度かかり、このことが使用感を阻害する場合があっ
た。従来、軟カプセル型入浴剤は次の如く製造される。
(図11)(特公昭61−12698号)即ち、ゼラチ
ン等を基剤とする皮膜液を加温して溶液状態とし、それ
を冷却ゲル化させ、フィルム状に成形した皮膜1を1対
の噛合回転する円筒型成形金型2の両側より狭間に送る
ように成してある。3は内容液4を貯溜したポンプ器筺
であり、前記円筒型成形金型2と連動するピストン5で
該内容液4を前記両側一対のフィルム状皮膜1の間に圧
入する。しかる時、該ポンプ器筺3によりフィルム状皮
膜1は適温に熱せられる為、円筒型成形金型2の表面に
形成される凸状の歯と歯の圧切によりヒ−トシ−ルされ
カプセル本体6が成形される。However, since the current soft capsule type bathing agent does not have sufficient film solubility, it takes about 8 to 10 minutes after the content of the bathing agent is released after the bath agent is poured into the bath water until the film is completely dissolved. However, this may hinder the usability. Conventionally, a soft capsule type bath agent is manufactured as follows.
(Fig. 11) (Japanese Examined Patent Publication No. 61-12698) That is, a coating solution based on gelatin or the like is heated to a solution state, cooled and gelated, and a pair of coatings 1 formed into a film are formed. It is configured such that it is fed from both sides of a cylindrical molding die 2 which is engaged and rotated to a narrow space. Reference numeral 3 denotes a pump housing which stores the content liquid 4, and the content liquid 4 is press-fitted between the pair of film-like coatings 1 on both sides by a piston 5 which is interlocked with the cylindrical molding die 2. At that time, since the film-like film 1 is heated to an appropriate temperature by the pump housing 3, the capsule body 6 is heat-sealed by the convex teeth formed on the surface of the cylindrical molding die 2 and the pressure cutting of the teeth. Is molded.
【0004】上記従来の装置で製造される場合、フィル
ム状皮膜1は図12に示すように円筒型成形金型2の回
転方向へ引っぱられながら切断されるため成形後のカプ
セルの接着部は図13に示すように接着部8及び9の厚
みが一定にならず特にカプセル下側の接着部9ではフィ
ルム状皮膜1が下方へ引っぱられながら切断される為該
接着部9が局部的に薄くなる事が多い。これまで経験的
に接着部(8、9)の厚さは乾燥時には最低0.1mm
以上なければ経時的に内容入浴剤の液漏れを招来する可
能性が高い事が知られている為、軟カプセル型入浴剤製
造時、接着部(8、9)の厚さを最低0.1mm以上と
なるようにフィルム状皮膜の厚さを設定する必要があ
り、前述した接着部(8、9)が局部的に薄くなること
を考慮すると充填時におけるフィルム状皮膜1の厚さを
0.9mm以上としなければならず軟カプセル型入浴剤
のカプセル総重量中に占める皮膜重量の割合、即ち、皮
膜率が10%を越えてしまい、又、皮膜厚さは0.2m
mを越えてしまうが、軟カプセル型入浴剤の浴湯への溶
解性を向上せしめる為に単に皮膜を薄くする事はできな
かった。When manufactured by the above conventional apparatus, the film-like film 1 is cut while being pulled in the rotational direction of the cylindrical molding die 2 as shown in FIG. As shown in 13, the thickness of the adhesive portions 8 and 9 is not constant, and particularly the adhesive portion 9 on the lower side of the capsule is cut while pulling the film-like film 1 downward, so that the adhesive portion 9 becomes locally thin. There are many things. Experience has shown that the thickness of the adhesive parts (8, 9) is at least 0.1 mm when dry.
It is known that if it is not above, there is a high possibility that the content of the bath agent will leak over time. Therefore, when manufacturing the soft capsule type bath agent, the thickness of the adhesive part (8, 9) should be at least 0.1 mm. It is necessary to set the thickness of the film-like coating so that the thickness of the film-like coating 1 at the time of filling is 0. It should be 9 mm or more, and the ratio of the coating weight to the total capsule weight of the soft capsule type bathing agent, that is, the coating rate exceeds 10%, and the coating thickness is 0.2 m.
Although it exceeds m, it was not possible to simply thin the film in order to improve the solubility of the soft capsule type bathing agent in the bath water.
【0005】又、医薬品や健康食品の軟カプセル剤の溶
解性を高める技術としては、様々な方法が提案されてい
る。例えば皮膜を形成するゼラチンにポリぺプチドを添
加する方法(特公昭60−9011)や同様にゼラチン
に対し酒石酸やクエン酸等の有機酸を添加する方法であ
る。しかし、これ等の技術はいずれも軟カプセル型入浴
剤には採用できない。なぜなら、前者の方法はゲル化能
がないポリぺプチドを皮膜の成分として添加する点で、
又、後者の方法はゼラチンが酸により加水分解されてし
まう点で共に製造された軟カプセル剤の強度が低下して
しまうからである。軟カプセル型入浴剤は医薬品、健康
食品等の経口目的の軟カプセルに比べ大型な製品が多く
カプセルの総重量が2g〜10gと重い為、強度的に不
十分である事は該軟カプセル型入浴剤の製造中あるいは
輸送中等におけるカプセルの割れ及び内容物の漏れ等を
誘発する可能性が高くなるため、これ等の通常の軟カプ
セル剤について提案された従来の技術は採用出来ないの
である。Various methods have been proposed as a technique for increasing the solubility of soft capsules for pharmaceuticals and health foods. For example, there is a method of adding a polypeptide to gelatin forming a film (Japanese Patent Publication No. 60-9011) or a method of adding an organic acid such as tartaric acid or citric acid to gelatin. However, none of these techniques can be adopted for soft capsule type bath salts. This is because the former method adds a polypeptide that has no gelling ability as a component of the film,
The latter method is also because the gelatin is hydrolyzed by an acid, so that the strength of the soft capsule preparation produced together with the gelatin decreases. Soft capsule-type bath agents are often large-sized products compared to soft capsules for oral use such as pharmaceuticals and health foods, and the total weight of the capsules is as heavy as 2 g to 10 g, so the strength is insufficient. Since there is a high possibility of inducing capsule cracking and leakage of contents during manufacturing or transportation of the drug, the conventional techniques proposed for these ordinary soft capsules cannot be adopted.
【0006】[0006]
【発明が解決しようとする課題】本発明が解決しようと
する課題は、軟カプセル型入浴剤に於いて、強度的に十
分であり、製造中又は輸送中等におけるカプセルの割れ
及び内容物の漏れ等の心配がなく、浴湯に投入した時の
溶解性を従来の製品よりも格段に向上させる点にある。The problem to be solved by the present invention is that the strength of a soft capsule type bathing agent is sufficient, cracking of the capsule and leakage of the contents during manufacture or transportation etc. There is no need to worry about it, and the solubility when added to bath water is significantly improved compared to conventional products.
【0007】[0007]
【課題を解決するための手段】尚、以下に説明する本発
明のカプセル製造装置は、軟カプセル型入浴剤の製造に
のみ限定使用されるものではなく、それ以外の他の充填
内容物を有する軟カプセルの製造にも使用されるもので
あることは勿論である。先ず、図1〜図5に基づいて説
明する。Pは本発明に係わるロ−タリ−式自動軟カプセ
ル製造機本体であり、円筒型成形金型20の表面には、
軟カプセル打抜き用の凹状型11を有する複数の独立し
た環状の主歯体12が縦横に適宜配設してある。11A
は貫通孔である。13は前記主歯体12と主歯体12と
の間に凸状に形成した副歯体(連続状態)で、その歯高
hは、主歯体12の歯高Hの50%〜100%程度が好
ましい。即ち、h=50〜100×H(%)である。通
常、この歯高hは歯高H以下であれば特に制限はない
が、均一な厚さの接着部を得るために上記の数値が良
い。The capsule manufacturing apparatus of the present invention described below is not limited to use for manufacturing a soft capsule type bathing agent, and has other filling contents. Of course, it is also used for manufacturing soft capsules. First, a description will be given with reference to FIGS. P is a rotary type automatic soft capsule manufacturing machine body according to the present invention, and the surface of the cylindrical molding die 20 is
A plurality of independent annular main tooth bodies 12 having a concave die 11 for punching soft capsules are appropriately arranged vertically and horizontally. 11A
Is a through hole. Reference numeral 13 denotes a sub tooth body (continuous state) formed in a convex shape between the main tooth body 12 and the main tooth body 12, and the tooth height h thereof is 50% to 100% of the tooth height H of the main tooth body 12. A degree is preferable. That is, h = 50 to 100 × H (%). Usually, this tooth height h is not particularly limited as long as it is equal to or less than the tooth height H, but the above numerical value is preferable in order to obtain a bonded portion having a uniform thickness.
【0008】次に図6〜図8について説明する。この実
施例の円筒型成形金型20の場合は副歯体13Aは1個
1個の主歯体12を独立して環状に取り囲んでいる(独
立状態)。この環状の副歯体13Aは主歯体12を一重
に囲撓しているが二重、三重・・・に取り囲んでも良
く、又環状が円形以外の他の形状でも良い。しかして、
前記した図3の場合は副歯体13は主歯体12と主歯体
12との間に単数しか形成されないが、図7の場合には
副歯体13Aが複数個形成されることとなる。Next, FIGS. 6 to 8 will be described. In the case of the cylindrical molding die 20 of this embodiment, the auxiliary tooth body 13A independently surrounds each main tooth body 12 in an annular shape (independent state). The ring-shaped auxiliary tooth body 13A surrounds the main tooth body 12 in a single layer, but may surround the main tooth body 12 in a double, triple, or the like, and the ring may have a shape other than a circle. Then,
In the case of FIG. 3 described above, only a single auxiliary tooth body 13 is formed between the main tooth body 12 and the main tooth body 12, but in the case of FIG. 7, a plurality of sub tooth bodies 13A are formed. ..
【0009】本発明に於いて円筒型成形金型20により
回転方向に引っぱられるフィルム状皮膜Fは、図4及び
図8に示す如く主歯体12間に形成した凸状を成す副歯
体(13、13A)によって接着面に押し入れられなが
ら打ち抜き用の凸状の主歯体12によって圧切されるた
め、従来の方法にみられた接着部が局部的に薄くなる事
がなく、均一な厚さの接着部(図9に示される14、1
5)が得られる。このため、従来の方法では接着厚さが
0.1mm以上となるように充填時に於いて、0.9m
m以上に設定されたフィルム状皮膜厚さが本発明では
0.9mm未満の任意の厚さに設定できる様になった。In the present invention, the film-like film F pulled in the rotational direction by the cylindrical molding die 20 is a sub-tooth body (convex shape) formed between the main tooth bodies 12 as shown in FIGS. 4 and 8. (13, 13A) is pressed into the adhesive surface while being pressed off by the convex main toothing 12 for punching, the adhesive part seen in the conventional method does not become thin locally and has a uniform thickness. Adhesive part (14, 1 shown in FIG. 9
5) is obtained. Therefore, in the conventional method, the adhesive thickness is 0.9 mm or more at the time of filling so that the adhesive thickness is 0.1 mm or more.
In the present invention, the film-like film thickness set to m or more can be set to any thickness less than 0.9 mm.
【0010】しかし、本発明で示される適正な製造時の
フィルム状皮膜厚さtは0.4mm〜0.7mmであ
る。いわゆる皮膜率が4%〜8%であり、この場合、フ
ィルム状皮膜厚さが0.4mm以下、換言すれば製品時
の皮膜率が4%以下であってもカプセル化は可能である
が、製品の強度や保存安定性が損なわれる可能性があり
又皮膜厚さが0.8mm〜0.9mmでは本発明者らが
目的とするところの溶解性の向上が十分に達成出来ない
からである。製造時、フィルム状皮膜厚さを0.4mm
〜0.7mmに調整された軟カプセル型入浴剤は、製品
時の皮膜率が4%〜8%であり、本発明製品Qたる軟カ
プセル型入浴剤の皮膜厚さは0.2mm以下とすること
ができる。However, the film-like film thickness t in the proper manufacturing shown in the present invention is 0.4 mm to 0.7 mm. The so-called coating rate is 4% to 8%, and in this case, encapsulation is possible even when the film coating thickness is 0.4 mm or less, in other words, the coating rate at the time of production is 4% or less, This is because the strength and storage stability of the product may be impaired, and if the film thickness is 0.8 mm to 0.9 mm, the desired improvement in solubility cannot be achieved by the inventors. .. At the time of production, the film thickness of the film is 0.4 mm
The soft capsule type bath agent adjusted to ~ 0.7 mm has a film rate of 4% to 8% at the time of product, and the film thickness of the soft capsule type bath agent of the product Q of the present invention is 0.2 mm or less. be able to.
【0011】[0011]
【実施例】次に、実施例、比較例、評価例によって本発
明を具体的に説明する。 実施例 (1)ゼラチン100kg,グリセリン30kg,精製
水95kgを70℃で3時間加熱攪拌して水溶液とし、
真空脱気した後60℃に保った保温釜に入れ、軟カプセ
ル型入浴剤用の皮膜剤とした。 (2)前述の本発明のロ−タリ−式自動軟カプセル製造
機本体Pを用いて(1)の皮膜剤を冷却ゲル化させ0.
5mm厚のフィルム状皮膜とした後、常法により界面活
性剤を主成分とするバスオイルを被包成形し、内容量8
gのラウンド160型軟カプセル型入浴剤を得た。EXAMPLES Next, the present invention will be specifically described with reference to Examples, Comparative Examples and Evaluation Examples. Example (1) 100 kg of gelatin, 30 kg of glycerin, and 95 kg of purified water were heated and stirred at 70 ° C. for 3 hours to prepare an aqueous solution.
After deaeration under vacuum, it was placed in a heat-retaining kettle kept at 60 ° C. to obtain a film agent for a soft capsule type bathing agent. (2) Using the rotary type automatic soft capsule manufacturing machine main body P of the present invention described above, the film forming agent of (1) is cooled and gelled.
After forming a film-like film with a thickness of 5 mm, a bath oil containing a surfactant as a main component is encapsulated by a conventional method to give a content of 8
g of round 160 type soft capsule type bath salt was obtained.
【0012】比較例 (1)実施例(1)の精製水を70kgとする他は実施
例(1)と同様な処方、方法にて皮膜剤を調整した。 (2)図11で示した通常のロ−タリ−式自動軟カプセ
ル製造装置を用いて比較例(1)の皮膜剤を冷却ゲル化
させ0.9mm厚のフィルム状皮膜とした後、常法によ
り実施例(2)と同様なバスオイルを被包成型し、内容
量8gのラウンド160型入浴剤を得た。Comparative Example (1) A coating agent was prepared by the same formulation and method as in Example (1) except that the purified water in Example (1) was 70 kg. (2) Using the ordinary rotary type automatic soft capsule manufacturing apparatus shown in FIG. 11, the film-forming agent of Comparative Example (1) was cooled and gelled to form a film-like film having a thickness of 0.9 mm, and then a conventional method was used. Thus, the same bath oil as in Example (2) was encapsulated to obtain a round 160 type bathing agent having an internal capacity of 8 g.
【0013】評価例 (1)接着厚さ測定 実施例及び比較例の軟カプセル型入浴剤の中心部を図1
0の如く切断し、実体顕微鏡にてA〜D各々の部位の厚
さを測定した。このとき、A及びBは接着部を示し、C
及びDは皮膜部を示す。上記結果を表1に示す。n=1
0の意味は同一種類のカプセル剤を10個採用し、各々
1回づつ延べ10回の試験を行ったことである。Evaluation Example (1) Measurement of Adhesion Thickness FIG. 1 shows the center portion of the soft capsule type bath salts of Examples and Comparative Examples.
It cut like 0, and measured the thickness of each part of AD with a stereoscopic microscope. At this time, A and B indicate an adhesive portion, and C
Symbols D and D indicate the film portion. The results are shown in Table 1. n = 1
The meaning of 0 is that 10 capsules of the same kind were adopted and each test was conducted once, 10 times in total.
【0014】[0014]
【表1】 [Table 1]
【0015】表1により示された如く実施例の軟カプセ
ル型入浴剤は比較例のそれに比べ接着部は厚く皮膜部は
薄かった。As shown in Table 1, the soft capsule type bath preparations of the examples had thicker adhesive parts and thinner film parts than those of the comparative examples.
【0016】(2)溶解試験 1リットルのビ−カ−に800mlの湯を入れ37±1
℃に保ち、その中に実施例及び比較例の軟カプセル型入
浴剤を入れヤマト化学(株)製のマグネチックスタ−ラ
−M41にて直径8mmφ長さ2.5cmの攪拌子を最
高回転(約1000rpm)にして攪拌した。この時、
該軟カプセル型入浴剤が内容入浴剤を放出し始める時間
を開口時間、皮膜が完全に溶解するまでの時間を溶解時
間として測定した。上記結果を表2に示す。(2) Dissolution test 800 ml of hot water was put into a 1 liter beaker and 37 ± 1.
The stirrer having a diameter of 8 mm and a length of 2.5 cm was rotated at maximum by using a magnetic stirrer M41 manufactured by Yamato Chemical Co., Ltd. The mixture was stirred at about 1000 rpm). At this time,
The time when the soft capsule type bathing agent started to release the content bathing agent was measured as the opening time, and the time until the film was completely dissolved was measured as the dissolution time. The above results are shown in Table 2.
【0017】[0017]
【表2】 [Table 2]
【0018】表2に示した様に実施例の軟カプセル型入
浴剤は比較例のそれに比べ開口時間は同等であったが溶
解に要する時間は1/3以下であった。As shown in Table 2, the soft capsule type bath agents of the Examples had the same opening time as that of the Comparative Example, but the time required for dissolution was 1/3 or less.
【0019】(3)強度測定 木屋式硬度計を用いて実施例及び比較例の軟カプセル型
入浴剤を圧縮して破裂した時の該入浴剤に加わった圧力
を破戒強度(kg)として測定した結果を表3に示す。(3) Strength Measurement Using a Kiya type hardness tester, the pressure applied to the soft capsule type bath additives of Examples and Comparative Examples when they were compressed and ruptured was measured as the crush strength (kg). The results are shown in Table 3.
【0020】[0020]
【表3】 [Table 3]
【0021】以上の評価例によって、本発明の軟カプセ
ル型入浴剤は従来の軟カプセル型入浴剤に比べて3倍以
上速く溶解するにも拘らず強度的に劣る事はなかった。
又、経時的に内容液の漏れの原因になる接着部の局部的
な薄さがみられない為、保存安定性が従来品に比べて向
上する事が示唆された。According to the above evaluation examples, the soft capsule type bathing agent of the present invention was not inferior in strength in spite of being three or more times faster than the conventional soft capsule type bathing agent.
In addition, it was suggested that the storage stability was improved as compared with the conventional product, because the adhesive part did not show a local thinness that would cause leakage of the content liquid over time.
【0022】[0022]
【発明の効果】以上説明したように、本発明では従来の
軟カプセル型入浴剤に比べて、製品の強度や保存安定性
を損なう事なく浴湯に投入した時の溶解性を格段に向上
させることができた。As described above, according to the present invention, compared with the conventional soft capsule type bath agents, the solubility when added to the bath water is significantly improved without deteriorating the strength and storage stability of the product. I was able to do it.
【図1】本発明に係わるカプセル製造機本体の概略全体
図である。FIG. 1 is a schematic overall view of a main body of a capsule manufacturing machine according to the present invention.
【図2】本発明の円筒型成形金型の斜視図である。FIG. 2 is a perspective view of a cylindrical molding die of the present invention.
【図3】図2のX−X線部分の拡大断面図である。FIG. 3 is an enlarged cross-sectional view taken along the line XX of FIG.
【図4】本発明の図3の主歯体と副歯体との関係を示す
要部の拡大縦断正面図である。FIG. 4 is an enlarged vertical sectional front view of a main part showing the relationship between the main tooth body and the sub tooth body of FIG. 3 of the present invention.
【図5】主歯体と副歯体との歯高の関係を示す拡大説明
図である。FIG. 5 is an enlarged explanatory view showing a tooth height relationship between a main tooth body and a sub tooth body.
【図6】他の実施例の円筒型成型金型の斜視図である。FIG. 6 is a perspective view of a cylindrical molding die of another embodiment.
【図7】図6のY−Y線部分の拡大断面図である。FIG. 7 is an enlarged sectional view of a portion taken along line YY of FIG.
【図8】図7に於ける主歯体と副歯体との関係を示す要
部の拡大縦断正面図である。FIG. 8 is an enlarged vertical sectional front view of a main part showing the relationship between the main tooth body and the sub tooth body in FIG.
【図9】本願品の拡大縦断正面図である。FIG. 9 is an enlarged vertical front view of the product of the present application.
【図10】本願品の拡大縦断正面図であって接着厚さ及
び皮膜厚さを測定する部位を示してある。FIG. 10 is an enlarged vertical front view of the product of the present application, showing a portion for measuring the adhesive thickness and the film thickness.
【図11】従来装置の説明図である。FIG. 11 is an explanatory diagram of a conventional device.
【図12】従来装置の要部の拡大縦断正面図である。FIG. 12 is an enlarged vertical sectional front view of a main part of a conventional device.
【図13】従来品の拡大縦断正面図である。FIG. 13 is an enlarged vertical sectional front view of a conventional product.
20・・・円筒型成形金型 11・・・凹状型 12・・・主歯体 13・・・副歯体 13A・・・副歯体 Q・・・本発明製品 20 ... Cylindrical molding die 11 ... Recessed mold 12 ... Main tooth body 13 ... Sub tooth body 13A ... Sub tooth body Q ... Product of the present invention
Claims (6)
に占める皮膜重量の割合が4%以上8%以下であること
を特徴とする軟カプセル型入浴剤1. A soft capsule type bath agent, wherein the ratio of the coating weight to the total capsule weight of the soft capsule type bath agent is 4% or more and 8% or less.
ることを特徴とする軟カプセル型入浴剤2. A soft capsule type bathing agent having a film thickness of 0.2 mm or less when manufactured.
を形成すると共に、該主歯体間に副歯体を連続状態に形
成した軟カプセル製造装置3. A soft capsule manufacturing apparatus in which a plurality of main tooth bodies are formed on the surface of a cylindrical molding die and auxiliary tooth bodies are continuously formed between the main tooth bodies.
を形成すると共に、該主歯体を取り囲んで副歯体を独立
状態に形成した軟カプセル製造装置4. A soft capsule manufacturing apparatus in which a plurality of main tooth bodies are formed on the surface of a cylindrical molding die and auxiliary tooth bodies are formed in an independent state so as to surround the main tooth bodies.
の歯高hを主歯体の歯高Hの50〜100%に成した軟
カプセル製造装置5. The soft capsule manufacturing apparatus according to claim 3, wherein the tooth height h of the auxiliary tooth body is 50 to 100% of the tooth height H of the main tooth body.
重・・・に取り巻いて形成した軟カプセル製造装置6. The soft capsule manufacturing apparatus according to claim 4, wherein the auxiliary tooth body is formed in a double triple structure.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3236965A JP2984105B2 (en) | 1991-08-23 | 1991-08-23 | Soft capsule manufacturing equipment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3236965A JP2984105B2 (en) | 1991-08-23 | 1991-08-23 | Soft capsule manufacturing equipment |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0551315A true JPH0551315A (en) | 1993-03-02 |
JP2984105B2 JP2984105B2 (en) | 1999-11-29 |
Family
ID=17008393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3236965A Expired - Lifetime JP2984105B2 (en) | 1991-08-23 | 1991-08-23 | Soft capsule manufacturing equipment |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2984105B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6589945B1 (en) | 1996-10-17 | 2003-07-08 | Cognis Deutschland Gmbh & Co. Kg | Use of sterolsulfates as active substances for producing means to inhibit serin proteases |
KR100459853B1 (en) * | 2002-01-21 | 2004-12-04 | 주식회사 보창 | Apparatus for supplying a medicine of manufacturing device for soft gelatine capsule |
WO2013100013A1 (en) * | 2011-12-28 | 2013-07-04 | 富士カプセル株式会社 | Soft capsule coating |
US10966907B2 (en) | 2014-10-31 | 2021-04-06 | Barlean's Organic Oils, Llc | Method and apparatus for the manufacture of softgels |
-
1991
- 1991-08-23 JP JP3236965A patent/JP2984105B2/en not_active Expired - Lifetime
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6589945B1 (en) | 1996-10-17 | 2003-07-08 | Cognis Deutschland Gmbh & Co. Kg | Use of sterolsulfates as active substances for producing means to inhibit serin proteases |
KR100459853B1 (en) * | 2002-01-21 | 2004-12-04 | 주식회사 보창 | Apparatus for supplying a medicine of manufacturing device for soft gelatine capsule |
WO2013100013A1 (en) * | 2011-12-28 | 2013-07-04 | 富士カプセル株式会社 | Soft capsule coating |
US10966907B2 (en) | 2014-10-31 | 2021-04-06 | Barlean's Organic Oils, Llc | Method and apparatus for the manufacture of softgels |
Also Published As
Publication number | Publication date |
---|---|
JP2984105B2 (en) | 1999-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2006322282B2 (en) | Foam wafer containing a polyvinyl alcohol-polyethyleneglycol-graft copolymer | |
JP4870386B2 (en) | Rapidly degradable administrable dosage forms for release of active ingredients in the oral cavity or body cavity | |
JP2001510785A (en) | Method for producing granules suitable for producing rapidly disintegrating oral dissolving tablets | |
JPH01502668A (en) | Oral compositions consisting of active substance-containing particles | |
AU2005251773B2 (en) | Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight | |
JPS61246120A (en) | Floating long life releasable therapeutical composition | |
MXPA00003182A (en) | Stable foam compositions. | |
JP4597662B2 (en) | Film-formable dissolvable formulations for active substance release and methods for their production | |
CA2341024A1 (en) | Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture | |
US20150140113A1 (en) | Gelling agent-based dosage form | |
JPH08333243A (en) | Tablet having excellent touch in oral cavity | |
JPH0551315A (en) | Soft capsule type bathing agent and device for producing soft capsule | |
EP0227050B1 (en) | Process for the preparation of single dosage administration forms, and administration forms thus obtained | |
GB2283172A (en) | Gelatin capsules | |
CN100544709C (en) | Antithrombotic chemical compound can be in mouth dispersive pharmaceutical composition | |
JPS59101420A (en) | Rectal composition containing indomethacin | |
EP0725625A1 (en) | Gelatin capsule fill able to foam | |
AU2005202270B2 (en) | Rapidly Disintegrating Dosage form For Releasing Nicotine in the Oral Cavity or in Body Cavities | |
JP6749903B2 (en) | Manufacturing method of easy-to-dose solid preparation and easy-to-dose solid preparation | |
WO2014125052A1 (en) | Pharmaceutical composition for oral administration comprising fexofenadine and process for preparing thereof | |
CA2506712C (en) | Rapidly-decomposing administrable form for releasing ingredients in the oral cavity or in bodily cavities | |
KR20200114174A (en) | Oral disintegration films containing nano-diamond cluster | |
JP2004175714A (en) | Resilient capsule preparation | |
JPH0259516A (en) | Membrane stimulating action aromatic transmitting system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 19990914 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080924 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090924 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090924 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100924 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110924 Year of fee payment: 12 |
|
EXPY | Cancellation because of completion of term |